neodisher SBX

Land: Verenigd Koninkrijk

Taal: Engels

Bron: DrWeigert

Koop het nu

Bijsluiter Bijsluiter (PIL)
22-09-2017
Productkenmerken Productkenmerken (SPC)
22-09-2017

Beschikbaar vanaf:

Dr. Weigert

Bijsluiter

                                Date revised: 06.10.2016
Print date: 26.05.17
3 / GB- 800069-013-01
Version: 3 / GB
Replaces Version: 2 /
GB
SAFETY DATA SHEET IN ACCORDANCE WITH REGULATION (EC) NO
1907/2006 NEODISHER SBX
Page 1(7)
SECTION 1: IDENTIFICATION OF THE SUBSTANCE/MIXTURE AND OF THE
COMPANY/UNDERTAKING
1.1. PRODUCT IDENTIFIER
neodisher SBX
1.2. RELEVANT IDENTIFIED USES OF THE SUBSTANCE OR MIXTURE AND USES
ADVISED AGAINST
USE OF THE SUBSTANCE/PREPARATION
Washing and cleaning products (including solvent based products)
1.3. DETAILS OF THE SUPPLIER OF THE SAFETY DATA SHEET
ADDRESS:
Chemische Fabrik Dr. Weigert GmbH & Co. KG
Mühlenhagen 85
D-20539 Hamburg
Telephone no.
+49 40 789 60 0
Fax no.
+49 40 789 60 120
www.drweigert.com
E-MAIL ADDRESS OF PERSON RESPONSIBLE FOR THIS SDS:
sida@drweigert.de
1.4. EMERGENCY TELEPHONE NUMBER
GBK/ Infotrac: (USA domestic) 1 800 535 5053 or international +1 352
323 3500
SECTION 2: HAZARDS IDENTIFICATION
2.1. CLASSIFICATION OF THE SUBSTANCE OR MIXTURE
This product is not classified hazardous in accordance with Regulation
(EC) No 1272/2008.
2.2. LABEL ELEMENTS
LABELLING ACCORDING TO REGULATION (EC) NO 1272/2008
HAZARD STATEMENTS
EUH210
Safety data sheet available on request.
2.3. OTHER HAZARDS
No special hazards have to be mentioned.
SECTION 3: COMPOSITION/INFORMATION ON INGREDIENTS
3.2. MIXTURES
FURTHER INGREDIENTS
ALANINE, N,N-BIS(CARBOXYMETHYL)-, TRISODIUM SALT
CAS No.
164462-16-2
EINECS no.
423-270-5
Registration no.
01-0000016977-53
Concentration
>=
1
<
5
%
SECTION 4: FIRST AID MEASURES
4.1. DESCRIPTION OF FIRST AID MEASURES
GENERAL INFORMATION
Date revised: 06.10.2016
Print date: 26.05.17
3 / GB- 800069-013-01
Version: 3 / GB
Replaces Version: 2 /
GB
SAFETY DATA SHEET IN ACCORDANCE WITH REGULATION (EC) NO
1907/2006 NEODISHER SBX
Page 2(7)
In case of persistent symptoms consult doctor.
AFTER INHALATION
Ensure supply of fresh air. In the event of symptoms take medical
treatment.
AFTER SKIN CONTACT
In case of contact with skin wash off with warm water. Consult a
doctor if skin irritation persists.
AFTER 
                                
                                Lees het volledige document
                                
                            

Documenten in andere talen

Bijsluiter Bijsluiter Spaans 22-09-2017
Productkenmerken Productkenmerken Spaans 22-09-2017
Bijsluiter Bijsluiter Duits 22-09-2017
Productkenmerken Productkenmerken Duits 22-09-2017
Bijsluiter Bijsluiter Frans 22-09-2017
Productkenmerken Productkenmerken Frans 22-09-2017
Bijsluiter Bijsluiter Italiaans 08-09-2017
Productkenmerken Productkenmerken Hongaars 22-09-2017
Bijsluiter Bijsluiter Nederlands 22-09-2017
Productkenmerken Productkenmerken Nederlands 22-09-2017
Bijsluiter Bijsluiter Pools 22-09-2017
Productkenmerken Productkenmerken Pools 22-09-2017

Zoekwaarschuwingen met betrekking tot dit product

Bekijk de geschiedenis van documenten